Life Technologies GlobalFiler Kit approved by FBI
01 July, 2014The United States Federal Bureau of Investigations (FBI) has granted approval of the Life Technologies GlobalFiler Kit, from Thermo Fisher Scientific, for forensic laboratories that generate DNA profiles and upload them to the Combined DNA Index System (CODIS) database.
Enzo Life Sciences cortisol ELISA kit
30 June, 2014 | Supplied by: United Bioresearch Products Pty LtdThe cortisol ELISA kit from Enzo Life Sciences can be used with a large variety of sample types and produces highly reproducible results for stress, autoimmune disease and cancer research.
Lonza L7 hiPSC Reprogramming and hPSC Culture System
27 June, 2014 | Supplied by: Capsugel Australia Pty LtdLonza introduces its L7 hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modelling, drug development and regenerative medicine. The offering includes tools to simplify and streamline the stem-cell culturing and reprogramming workflow.
First images of a microorganism's drug manufacturing line
23 June, 2014Researchers at the University of Michigan (UM) have obtained the first three-dimensional snapshots of the 'assembly line' within microorganisms that naturally produces antibiotics and other drugs.
Hunting for breast cancer risk with next-gen sequencing
20 June, 2014 by Lauren DavisThe Hunter Medical Research Institute's (HMRI) Pathology Service laboratory has developed DNA sequencing technology that is accelerating screening for the genetic risk of breast and ovarian cancer.
Targeting bacteria's antibiotic-resistant barrier
20 June, 2014Scientists at the University of East Anglia (UEA) have discovered what they believe to be an Achilles heel in the defensive barrier which surrounds drug-resistant bacterial cells.
Jumping genes and the rise of flowering plants
19 June, 2014Scientists from Murdoch University have developed a theory of evolution that explains what Charles Darwin described as an "abominable mystery" - the rapid rise of flowering plants.
Qiagen artus CMV RGQ MDx Kit
19 June, 2014 | Supplied by: QIAGEN Pty LtdQiagen's artus CMV RGQ MDx Kit for human cytomegalovirus (CMV) has been approved by the US Food and Drug Administration (FDA) under a full premarket approval (PMA). The PCR-based assay is optimised for low- to mid-throughput testing of CMV.
Promega CellTiter-Glo 3D Cell Viability Assay for 3D microtissue culture
17 June, 2014 | Supplied by: Promega Pty LtdPromega has launched an assay validated for assessing the viability of cells in three-dimensional (3D) microtissue model systems. CellTiter-Glo 3D Cell Viability Assay penetrates large 3D microtissue samples to provide accurate determination of viable cells.
Applikon Biotechnology micro-Matrix microbioreactor
16 June, 2014 | Supplied by: John Morris Scientific Pty Ltdmicro-Matrix offers an integrated, easy-to-use technology platform for the rapid handling and growth of large numbers of microbial strains, clone libraries, mutant banks and cells.
Eucalyptus genome successfully sequenced
12 June, 2014The genetic blueprint of the Eucalyptus grandis (flooded gum) has been sequenced for the first time. The five-year effort to analyse the 640 million base-pair genome was conducted by 80 researchers from 30 institutions across 18 countries.
Manipulating stem cells to repair brain damage
04 June, 2014A scientist from Queensland University of Technology (QUT) is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.
Tasmanian blood sampling technology licensed
02 June, 2014The University of Tasmania and commercialisation company Housefield have signed an intellectual property licensing agreement to develop the blood sampling technology known as MilliSpot.
Australia rises to the challenge of creating synthetic yeast
29 May, 2014 by Lauren DavisAustralia has joined the Yeast 2.0 project, an international effort to create the world's first ever synthetic complex organism: a particular strain of yeast.
DiaSorin LIAISON Ixt/Arrow BUGS'n BEADS extraction kits
29 May, 2014 | Supplied by: DiaSorin Australia Pty LtdClinical laboratories are preparing for an increase in test requests for certain seasonal pathogens, such as norovirus and Mycoplasma pneumonia. The DiaSorin BUGS'n BEADS nucleic acid extraction kits, for use with the automated DiaSorin LIAISON Ixt/Arrow instruments, provide a highly purified nucleic acid preparation from patient samples for sensitive molecular confirmation.
